For this World Cancer Day on February 4th, INCA launches a 10-day #NETinfo campaign for an earlier detection of #NeuroendocrineCancer to highlight the key neuroendocrine cancer facts and emphasize that cancer does not stop for COVID-19.
The 10-day #NETinfo campaign will share essential data around the disease, the common conditions which it most often mimics, and the challenge of delayed diagnosis. Everyone can contribute to improving detection of neuroendocrine cancer by helping to raise awareness about the disease symptoms and common misdiagnoses. The campaign will also provide the most up-to-date information pack on #NeuroendocrineCancer, which is available for free download in 10 of the most spoken languages globally.
With this campaign INCA expresses its gratitude to the whole healthcare community for its continuous and tireless efforts in the COVID-19 fight. INCA also celebrates the strong community spirit of all neuroendocrine cancer patients, their families and caregivers through the pandemic. INCA would like to especially thank all healthcare professionals, researchers, and patient advocates for their unwavering display of energy and dedication in doing their best to prioritize neuroendocrine cancer during these challenging times and in keeping up the high standards of neuroendocrine cancer care.
One example of these collaborative efforts is the article published in the European Journal of Cancer: “Practical Recommendations for the Management of Patients With Gastroenteropancreatic and Thoracic (Carcinoid) Neuroendocrine Neoplasms (NENs) in the COVID-19 Era”, co-authored by top NET medical experts from around the globe, along with leading NET patient advocates –
Catherine Bouvier, INCA President, Jackie Herman, INCA Board Member, and Teodora Kolarova, INCA Executive Director.
Join the 10-day #NETinfo campaign via INCA’s social media accounts @netcancerday
